Beijing Konruns Pharmaceutical Co.,Ltd. (603590.SS)
CNY 30.67
(0.23%)
CNY 30.67
(0.23%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -80.42 Million CNY | 75.84% |
| 2022 | -332.82 Million CNY | 42.66% |
| 2021 | -580.45 Million CNY | 56.1% |
| 2020 | -1.32 Billion CNY | 26.67% |
| 2019 | -1.8 Billion CNY | -6.7% |
| 2018 | -1.68 Billion CNY | -211.36% |
| 2017 | -542.72 Million CNY | -153.57% |
| 2016 | -214.03 Million CNY | -517.33% |
| 2015 | -34.67 Million CNY | 13.17% |
| 2014 | -39.93 Million CNY | 64.61% |
| 2013 | -112.83 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q3 | -103.07 Million CNY | -30.49% |
| 2024 Q1 | -138.02 Million CNY | -71.62% |
| 2024 Q2 | -78.99 Million CNY | 42.77% |
| 2023 Q2 | -65.05 Million CNY | 70.36% |
| 2023 FY | -80.42 Million CNY | 75.84% |
| 2023 Q3 | -203.78 Million CNY | -213.27% |
| 2023 Q4 | -80.42 Million CNY | 60.54% |
| 2023 Q1 | -219.47 Million CNY | 34.06% |
| 2022 Q3 | -512.35 Million CNY | 6.24% |
| 2022 Q1 | -522 Million CNY | 10.07% |
| 2022 FY | -332.82 Million CNY | 42.66% |
| 2022 Q4 | -332.82 Million CNY | 35.04% |
| 2022 Q2 | -546.44 Million CNY | -4.68% |
| 2021 Q2 | -1.02 Billion CNY | -0.94% |
| 2021 FY | -580.45 Million CNY | 56.1% |
| 2021 Q4 | -580.45 Million CNY | 40.99% |
| 2021 Q3 | -983.63 Million CNY | 4.47% |
| 2021 Q1 | -1.02 Billion CNY | 22.85% |
| 2020 Q3 | -1.52 Billion CNY | 24.27% |
| 2020 Q4 | -1.32 Billion CNY | 13.32% |
| 2020 FY | -1.32 Billion CNY | 26.67% |
| 2020 Q2 | -2.01 Billion CNY | -8.46% |
| 2020 Q1 | -1.85 Billion CNY | -3.01% |
| 2019 FY | -1.8 Billion CNY | -6.7% |
| 2019 Q4 | -1.8 Billion CNY | -4.41% |
| 2019 Q3 | -1.72 Billion CNY | -2.88% |
| 2019 Q1 | -1.68 Billion CNY | 0.02% |
| 2019 Q2 | -1.67 Billion CNY | 0.65% |
| 2018 Q4 | -1.68 Billion CNY | -4.7% |
| 2018 FY | -1.68 Billion CNY | -211.36% |
| 2018 Q1 | 545.92 Million CNY | 200.59% |
| 2018 Q2 | -613.81 Million CNY | -212.43% |
| 2018 Q3 | -1.61 Billion CNY | -162.94% |
| 2017 Q4 | -542.72 Million CNY | 0.0% |
| 2017 FY | -542.72 Million CNY | -153.57% |
| 2016 Q4 | -214.03 Million CNY | 0.0% |
| 2016 FY | -214.03 Million CNY | -517.33% |
| 2016 Q2 | -54.19 Million CNY | 0.0% |
| 2015 FY | -34.67 Million CNY | 13.17% |
| 2014 FY | -39.93 Million CNY | 64.61% |
| 2013 FY | -112.83 Million CNY | 0.0% |